Irish Life Investment Managers’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Irish Life Investment Managers’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$131K	Buy	+7,504	New	+$133K	﹤0.01%	825

Other funds holding ARIA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Irish Life Investment Managers's ARIA Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in Ariad Pharmaceuticals Inc (ARIA) in Q2 2013: 7,504 shares worth $131K. The stake represents ﹤0.01% of the portfolio and ranks #825 among its holdings.

198 funds tracked by Wall St. Rank hold ARIA as of Q2 2013.

Irish Life Investment Managers held 7,504 shares of Ariad Pharmaceuticals Inc worth $131K as of Q2 2013.
Ariad Pharmaceuticals Inc was a new Irish Life Investment Managers position in Q2 2013.
Ariad Pharmaceuticals Inc made up ﹤0.01% of Irish Life Investment Managers's portfolio in Q2 2013, its #825 holding.
198 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.